Multicentre TARE Registry for HCC

We analysed 422 patients with HCC collected in the CIRSE Registry for SIR-Spheres Therapy (CIRT) study. CIRT is a prospective, single device, multi-centre observational study of patients with primary and metastatic hepatic malignancies treated with TARE using Y90 resin microspheres as the standard of care. The CIRT methodology was published by Helmberger et al.²⁶ Sites were invited to participate if they had at least 40 TARE cases and 10 cases in 12 months prior to invitation. In total, 27 participating sites in eight countries were identified and enrolled from April 2014 until April 2017, of which 25 sites included patients with HCC.²⁵ (link)
Data was collected using a customised electronic data capturing system and electronic case report form that was developed by ConexSys Inc (Lincoln, RI, United States) and hosted on a local secure server in Vienna, Austria maintained by ITEA (Vienna, Austria). Statistical analyses were performed in SAS 9.4 (SAS Institute, Cary, NC, USA) and RStudio under R4.0.0 (R Foundation, Vienna, Austria, Supplementary CTAT Table).

Free full text: Click here

Kolligs F., Arnold D., Golfieri R., Pech M., Peynircioglu B., Pfammatter T., Ronot M., Sangro B., Schaefer N., Maleux G., Munneke G., Pereira H., Zeka B., de Jong N, & Helmberger T. (2022). Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study. JHEP Reports, 5(2), 100633.

Publication 2022

SAS 9.4 RStudio under R4.0.0

Cirt Device Metastatic malignancies Microspheres Patients Resin Tare Therapy

Corresponding Organization : Cardiovascular and Interventional Radiological Society of Europe

Other organizations : Helios Hospital Berlin-Buch, Asklepios Klinik Altona, Azienda USL di Bologna, University Hospital Magdeburg, Hacettepe University, University of Zurich, University Hospital of Zurich, Université Paris Cité, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red, University Hospital of Lausanne, Universitair Ziekenhuis Leuven, University College London Hospitals NHS Foundation Trust, University College London, Hôpital Européen, Hôpital Européen Georges-Pompidou, Inserm, München Klinik Bogenhausen

Top 5 similar protocols

Variable analysis

independent variables

Treatment with TARE using Y90 resin microspheres

dependent variables

Outcomes in patients with primary and metastatic hepatic malignancies

control variables

Sites that had at least 40 TARE cases and 10 cases in 12 months prior to invitation

controls

No positive or negative controls were explicitly mentioned in the provided information.

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!